{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"free-sialic-acid-storage-disease","columns":[{"gene":"","key":"population-64b3e50f287521c1ef9a","label":"Free sialic acid storage disease","mondoId":"MONDO:0019366","onsetQualifier":null,"originColumnKey":"MONDO:0019366/ORPHA:834","originalViews":[{"key":"MONDO:0019366/ORPHA:834","label":"Free sialic acid storage disease","scopeLabel":"ORPHA:834","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["01561456aa2d154136c8510ae0a7d3ed0f5dcfe45de88d6f09d087d5a1fc6c10","02850247083402968197031825ce3de29f23921fe5a89247262212c5893957ff","06b7cc228e6b4b3b96d8c1989b0167fe3475525d7e2d48c994dc25a67d324ebb","06e28cdf4ada2e6b6656567519c36a43e23783a1c34fb5d2295608fee6384a86","0ec45d2eefd0549b7e08de2e33499c1b1edb606b150a223705350b54c1c2d04c","1f49cad206e36c340158af74670698d0b971b8c8b980a96cd5aad73cd083ef52","1f778826c621702ca9c0c185e783a4ce82aa99576fe754c24c8682743680bcf7","3a6223a70bb49f6c4e8b2950b0946f9ce29c24c3798325a498601a75f2138304","3b1ffb1df006f96017c4323200b64c61674b8c32599bad4c092231f62b902d41","46bead95f7385c6e1202e4c15411e7846221d4f2d419fcf7374654536669041c","4e7a1f08d992b338f3b8d42c5f05a0027fc8db117e62719cd6c7ac07bb2e5331","507bda5df863dd5ade1c49752b93fa1516fc69253057c82cea1de09332eb0f21","599d6bec47ab59b7aafd53cc479e8cd5d3d1fdcad21b4a6b02996b20660b14f2","7102214cd15065b902fb6ec8717d2f11c0bf29954a6abef00259cd15b78efd4e","72abb89fcb0631ccf9f18d11a3416327148e6be1306aad4eefae8bd88dda4c7b","79c1488b279af6e30dc1169cf2e66eef8a4f735da96fe68763fe271dddaeab68","865ee9b15d664e6a15fe522d4211550340aaea0897dc4f4c26f64062b63aa2f0","8782e9bcea34c83d903a97bf676d9a224ef5cab080632447906e8850f99b04c1","90762bee57719d156b7f262f03f89391998ead520c8e9f24c160758d04ab8c05","96b8dda949416924f48dbf773d5e110667b6a984c866b8c83e0ca8620b6268d8","aa818478a796ff670c25b7cc41ebfd2c44512ec25e1a15abe02dcb48505c146a","b3ac27f6fd7cabb3c387ea1f74b6e204517f747b5add3ee2f1daa74daf351167","b3e0120879a9469db05c40354d5504fe7fd11ccd6df191858955f15dd1cdf373","c0635ea0b420296b3255629a2b8c5b473509fa0efc996610e4d0967e9fd75217","c9a25cd36b60694ad5fd9d5fd74fa3861fce80cdd0f748f8cbb0f4b7b90fc7f9","cceca11306ec9e32198fbaaf6fb23fe955c5d3812930d9b2e2623c9fcc7e5977","d6775af94a43d80c50a2eab18fcd6bf08c15f4581c463af93a6ba220ce1d60d5","e2c3827c6b5ad3cf1ec39aff9051c3a0ca234d5258d666bca92cac567ef07e4b","f25d113ed6ab2375f57a00c11ba7bde6595551b712290f43d453bc2cc6ff259e","f46b57c0ae4ee54f4780d68254b8963886145d43450017ef838283785f15f81e"],"recordQualifiers":{},"scopeLabel":"ORPHA:834","sourceIds":["ORPHA:834"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-64b3e50f287521c1ef9a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001999","HP:0001760","HP:0007256","HP:0001000","HP:0002167","HP:0002817","HP:0010318"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":30,"sourceGroups":{"orphanet":30}},"features":[{"hpoId":"HP:0001999","label":"Abnormal facial shape","primary":true},{"hpoId":"HP:0001760","label":"Abnormal foot morphology","primary":true},{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0001000","label":"Abnormal skin pigmentation","primary":true},{"hpoId":"HP:0002167","label":"Abnormal speech pattern","primary":true},{"hpoId":"HP:0002817","label":"Abnormality of the upper limb","primary":true},{"hpoId":"HP:0010318","label":"Aplasia/Hypoplasia of the abdominal wall musculature","primary":true},{"hpoId":"HP:0001541","label":"Ascites","primary":false},{"hpoId":"HP:0001251","label":"Ataxia","primary":false},{"hpoId":"HP:0002305","label":"Athetosis","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0001531","label":"Failure to thrive in infancy","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001789","label":"Hydrops fetalis","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0007730","label":"Iris hypopigmentation","primary":false},{"hpoId":"HP:0000100","label":"Nephrotic syndrome","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000657","label":"Oculomotor apraxia","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":false},{"hpoId":"HP:0004349","label":"Reduced bone mineral density","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002652","label":"Skeletal dysplasia","primary":false},{"hpoId":"HP:0200042","label":"Skin ulcer","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"Free sialic acid storage disorder (FSASD) is an inherited condition that primarily affects the brain and spinal cord (central nervous system). The signs and symptoms of FSASD can vary from person to person, and the condition is often divided into three forms based on the severity of these features. The severe form of FSASD is called infantile free sialic acid storage disease or ISSD. The signs and symptoms of this form typically appear in infancy. In some cases, a condition called hydrops fetalis, in which excess fluid accumulates in the body, occurs before or soon after birth. Babies with the severe form of FSASD typically have severe developmental delays, weak muscle tone (hypotonia), and an inability to gain weight and grow at the expected rate (failure to thrive). Additional signs and symptoms may include unusual facial features that are often described as &#x27;coarse,&#x27; bone malformations, an enlarged liver and spleen (hepatosplenomegaly), an enlarged heart (cardiomegaly), and seizures. Respiratory infections are common and can be life-threatening; children with the severe form of FSASD typically only survive into early childhood. Children with the least severe form of FSASD, also called Salla disease, may not have the signs and symptoms of the condition at birth. The age at which people develop the signs and symptoms of Salla disease can vary, but hypotonia usually appears during the first year of life. People with Salla disease typically have intellectual disabilities and developmental delays, which can make it difficult for them to learn to walk and talk. Additional signs and symptoms include problems with movement and balance (ataxia); abnormal tensing of the muscles (spasticity); and involuntary slow, writhing movements of the limbs (athetosis). Signs and symptoms typically worsen over time. Although life expectancy may be shortened, individuals with Salla disease often survive into adulthood. People with the intermediate form of FSASD, also called intermediate severe Salla disease, have signs and symptoms that are typically more severe than the signs and symptoms seen in people with Salla disease and less severe than those seen in people with ISSD.","mondoId":"MONDO:0019366","node":{"canonicalSlug":"free-sialic-acid-storage-disease","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Free sialic acid storage disease","originalSourceId":"ORPHA:834","paragraphs":["Free sialic acid storage disorder (FSASD) is an inherited condition that primarily affects the brain and spinal cord (central nervous system). The signs and symptoms of FSASD can vary from person to person, and the condition is often divided into three forms based on the severity of these features. The severe form of FSASD is called infantile free sialic acid storage disease or ISSD. The signs and symptoms of this form typically appear in infancy. In some cases, a condition called hydrops fetalis, in which excess fluid accumulates in the body, occurs before or soon after birth. Babies with the severe form of FSASD typically have severe developmental delays, weak muscle tone (hypotonia), and an inability to gain weight and grow at the expected rate (failure to thrive). Additional signs and symptoms may include unusual facial features that are often described as 'coarse,' bone malformations, an enlarged liver and spleen (hepatosplenomegaly), an enlarged heart (cardiomegaly), and seizures. Respiratory infections are common and can be life-threatening; children with the severe form of FSASD typically only survive into early childhood. Children with the least severe form of FSASD, also called Salla disease, may not have the signs and symptoms of the condition at birth. The age at which people develop the signs and symptoms of Salla disease can vary, but hypotonia usually appears during the first year of life. People with Salla disease typically have intellectual disabilities and developmental delays, which can make it difficult for them to learn to walk and talk. Additional signs and symptoms include problems with movement and balance (ataxia); abnormal tensing of the muscles (spasticity); and involuntary slow, writhing movements of the limbs (athetosis). Signs and symptoms typically worsen over time. Although life expectancy may be shortened, individuals with Salla disease often survive into adulthood. People with the intermediate form of FSASD, also called intermediate severe Salla disease, have signs and symptoms that are typically more severe than the signs and symptoms seen in people with Salla disease and less severe than those seen in people with ISSD."],"rawAttribution":"MONDO:0019366","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:23Z","upstream":"GARD:0010870","url":"https://rarediseases.info.nih.gov/diseases/10870"},"ownColumnKeys":["population-64b3e50f287521c1ef9a"],"publication":"published","relationships":[{"kind":"parent","label":"inborn disorder of lysosomal amino acid transport","mondoId":"MONDO:0019246","slug":null},{"kind":"child","label":"free sialic acid storage disease, infantile form","mondoId":"MONDO:0010027","slug":"free-sialic-acid-storage-disease-infantile-form"},{"kind":"child","label":"sialuria","mondoId":"MONDO:0010028","slug":"sialuria"},{"kind":"child","label":"Salla disease","mondoId":"MONDO:0011449","slug":"salla-disease"},{"kind":"child","label":"intermediate severe Salla disease","mondoId":"MONDO:0017737","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"01561456aa2d154136c8510ae0a7d3ed0f5dcfe45de88d6f09d087d5a1fc6c10","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001999","is_excluded":false,"label":"Abnormal facial shape","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"02850247083402968197031825ce3de29f23921fe5a89247262212c5893957ff","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001760","is_excluded":false,"label":"Abnormal foot morphology","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"06b7cc228e6b4b3b96d8c1989b0167fe3475525d7e2d48c994dc25a67d324ebb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"06e28cdf4ada2e6b6656567519c36a43e23783a1c34fb5d2295608fee6384a86","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010318","is_excluded":false,"label":"Aplasia/Hypoplasia of the abdominal wall musculature","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ec45d2eefd0549b7e08de2e33499c1b1edb606b150a223705350b54c1c2d04c","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1f49cad206e36c340158af74670698d0b971b8c8b980a96cd5aad73cd083ef52","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1f778826c621702ca9c0c185e783a4ce82aa99576fe754c24c8682743680bcf7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a6223a70bb49f6c4e8b2950b0946f9ce29c24c3798325a498601a75f2138304","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001541","is_excluded":false,"label":"Ascites","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b1ffb1df006f96017c4323200b64c61674b8c32599bad4c092231f62b902d41","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002305","is_excluded":false,"label":"Athetosis","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46bead95f7385c6e1202e4c15411e7846221d4f2d419fcf7374654536669041c","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0200042","is_excluded":false,"label":"Skin ulcer","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e7a1f08d992b338f3b8d42c5f05a0027fc8db117e62719cd6c7ac07bb2e5331","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"507bda5df863dd5ade1c49752b93fa1516fc69253057c82cea1de09332eb0f21","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001789","is_excluded":false,"label":"Hydrops fetalis","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"599d6bec47ab59b7aafd53cc479e8cd5d3d1fdcad21b4a6b02996b20660b14f2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7102214cd15065b902fb6ec8717d2f11c0bf29954a6abef00259cd15b78efd4e","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007730","is_excluded":false,"label":"Iris hypopigmentation","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72abb89fcb0631ccf9f18d11a3416327148e6be1306aad4eefae8bd88dda4c7b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"79c1488b279af6e30dc1169cf2e66eef8a4f735da96fe68763fe271dddaeab68","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"865ee9b15d664e6a15fe522d4211550340aaea0897dc4f4c26f64062b63aa2f0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8782e9bcea34c83d903a97bf676d9a224ef5cab080632447906e8850f99b04c1","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001531","is_excluded":false,"label":"Failure to thrive in infancy","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"90762bee57719d156b7f262f03f89391998ead520c8e9f24c160758d04ab8c05","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96b8dda949416924f48dbf773d5e110667b6a984c866b8c83e0ca8620b6268d8","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aa818478a796ff670c25b7cc41ebfd2c44512ec25e1a15abe02dcb48505c146a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002652","is_excluded":false,"label":"Skeletal dysplasia","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3ac27f6fd7cabb3c387ea1f74b6e204517f747b5add3ee2f1daa74daf351167","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001000","is_excluded":false,"label":"Abnormal skin pigmentation","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3e0120879a9469db05c40354d5504fe7fd11ccd6df191858955f15dd1cdf373","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0635ea0b420296b3255629a2b8c5b473509fa0efc996610e4d0967e9fd75217","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000657","is_excluded":false,"label":"Oculomotor apraxia","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9a25cd36b60694ad5fd9d5fd74fa3861fce80cdd0f748f8cbb0f4b7b90fc7f9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cceca11306ec9e32198fbaaf6fb23fe955c5d3812930d9b2e2623c9fcc7e5977","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002167","is_excluded":false,"label":"Abnormal speech pattern","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d6775af94a43d80c50a2eab18fcd6bf08c15f4581c463af93a6ba220ce1d60d5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002817","is_excluded":false,"label":"Abnormality of the upper limb","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e2c3827c6b5ad3cf1ec39aff9051c3a0ca234d5258d666bca92cac567ef07e4b","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000100","is_excluded":false,"label":"Nephrotic syndrome","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f25d113ed6ab2375f57a00c11ba7bde6595551b712290f43d453bc2cc6ff259e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f46b57c0ae4ee54f4780d68254b8963886145d43450017ef838283785f15f81e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:834","disease_name":"Free sialic acid storage disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004349","is_excluded":false,"label":"Reduced bone mineral density","onset_id":null,"reference":"ORPHA:834","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10870\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019366\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010870</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Free sialic acid storage disorder (FSASD) is an inherited condition that primarily affects the brain and spinal cord (central nervous system). The signs and symptoms of FSASD can vary from person to person, and the condition is often divided into three forms based on the severity of these features. The severe form of FSASD is called infantile free sialic acid storage disease or ISSD. The signs and symptoms of this form typically appear in infancy. In some cases, a condition called hydrops fetalis, in which excess fluid accumulates in the body, occurs before or soon after birth. Babies with the severe form of FSASD typically have severe developmental delays, weak muscle tone (hypotonia), and an inability to gain weight and grow at the expected rate (failure to thrive). Additional signs and symptoms may include unusual facial features that are often described as &#x27;coarse,&#x27; bone malformations, an enlarged liver and spleen (hepatosplenomegaly), an enlarged heart (cardiomegaly), and seizures. Respiratory infections are common and can be life-threatening; children with the severe form of FSASD typically only survive into early childhood. Children with the least severe form of FSASD, also called Salla disease, may not have the signs and symptoms of the condition at birth. The age at which people develop the signs and symptoms of Salla disease can vary, but hypotonia usually appears during the first year of life. People with Salla disease typically have intellectual disabilities and developmental delays, which can make it difficult for them to learn to walk and talk. Additional signs and symptoms include problems with movement and balance (ataxia); abnormal tensing of the muscles (spasticity); and involuntary slow, writhing movements of the limbs (athetosis). Signs and symptoms typically worsen over time. Although life expectancy may be shortened, individuals with Salla disease often survive into adulthood. People with the intermediate form of FSASD, also called intermediate severe Salla disease, have signs and symptoms that are typically more severe than the signs and symptoms seen in people with Salla disease and less severe than those seen in people with ISSD.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10870\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"free-sialic-acid-storage-disease","sourceDocuments":[{"name":"GARD: Free sialic acid storage disease","reviewed":null,"source_release":"2026-10-25T03:41:23Z","url":"https://rarediseases.info.nih.gov/diseases/10870"},{"name":"MONDO: free sialic acid storage disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019366"}],"sourceNote":"","synonyms":["free sialic acid storage disease"],"takeawayHtml":"","title":"free sialic acid storage disease"},"schemaVersion":1}
